Finanzas de CME Group Inc (CME)CMECME Group Inc

Evaluating the bottom line, CME Group Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 80.90%, while the net margin is 33.22%. These profitability ratios, combined with a Return on Equity (ROE) of 15.72%, provide a clear picture of how effectively CME converts its operational activities into shareholder value.

In the context of the broader market, CME competes directly with industry leaders such as BNY and HOOD. With a market capitalization of $97.01B, it holds a significant position in the sector. When comparing efficiency, CME's gross margin of N/A stands against BNY's N/A and HOOD's 95.26%. Such benchmarking helps identify whether CME Group Inc. is trading at a premium or discount relative to its financial performance.

CME Group has shown solid revenue growth, with total revenue for Q2 2026 at $3.136 billion and a net income of $1.041 billion, resulting in a net margin of 33.22%. The forward P/E ratio is 22.94, which is relatively high, indicating potential overvaluation.